Overview

QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa®)

Status:
Completed
Trial end date:
2018-01-02
Target enrollment:
Participant gender:
Summary
This national, observational and multicentre study aims at establishing a picture of real clinical practices management among patients treated with Pentasa®, according to the current therapeutic strategy in proctitis or distal proctosigmoiditis. This study should be able to provide data on patients' health related quality of life, compliance and efficacy in real clinical practice
Details
Lead Sponsor:
Ferring Pharmaceuticals
Treatments:
Mesalamine